ArticleJournal for immunotherapy of cancer2025

Engineered IL-18 variants with half-life extension and improved stability for cancer immunotherapy.

Travis W Bainbridge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.